Osaic Holdings’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$19.6M Buy
44,896
+11,347
+34% +$4.95M 0.04% 420
2025
Q1
$16.3M Sell
33,549
-15,754
-32% -$7.64M 0.04% 489
2024
Q4
$15.2M Sell
49,303
-143
-0.3% -$43.9K 0.03% 490
2024
Q3
$23M Sell
49,446
-3,649
-7% -$1.7M 0.05% 362
2024
Q2
$24.9M Sell
53,095
-7,464
-12% -$3.5M 0.06% 337
2024
Q1
$25.3M Sell
60,559
-35,387
-37% -$14.8M 0.06% 337
2023
Q4
$39M Sell
95,946
-20,228
-17% -$8.23M 0.07% 262
2023
Q3
$40.4M Buy
116,174
+51,198
+79% +$17.8M 0.06% 305
2023
Q2
$22.8M Buy
64,976
+4,824
+8% +$1.7M 0.04% 413
2023
Q1
$19M Buy
60,152
+2,380
+4% +$750K 0.04% 472
2022
Q4
$16.7M Sell
57,772
-4,952
-8% -$1.43M 0.03% 500
2022
Q3
$18.2M Buy
62,724
+2,665
+4% +$772K 0.04% 408
2022
Q2
$16.9M Buy
60,059
+5,159
+9% +$1.46M 0.04% 441
2022
Q1
$14.1M Buy
54,900
+6,371
+13% +$1.63M 0.03% 582
2021
Q4
$10.7M Buy
48,529
+15,222
+46% +$3.34M 0.02% 712
2021
Q3
$6.04M Sell
33,307
-4,083
-11% -$741K 0.01% 947
2021
Q2
$7.54M Sell
37,390
-4,539
-11% -$915K 0.02% 809
2021
Q1
$9M Buy
41,929
+6,384
+18% +$1.37M 0.02% 642
2020
Q4
$8.4M Buy
35,545
+3,312
+10% +$783K 0.02% 589
2020
Q3
$8.81M Sell
32,233
-12,541
-28% -$3.43M 0.03% 510
2020
Q2
$13M Buy
44,774
+3,359
+8% +$975K 0.04% 352
2020
Q1
$7.05M Buy
+41,415
New +$7.05M 0.03% 485